Particle and droplet size directly influence the bioavailibility and manufacturability of liquid and solid formulations. For example, the development of topical products requires tight control of droplet size and a clear understanding of how the process parameters chosen at each scale influences stability. Tablets break apart into small particles during dissolution testing and the rate of disintegration directly influences Active Pharmaceutical Ingredients (API) release rate. Suspensions used to fill meter dose inhalers require tight control over particle size to ensure efficacy for the patient.